Skip to Content

Ticagrelor use while Breastfeeding

Drugs containing Ticagrelor: Brilinta

Medically reviewed by Drugs.com. Last updated on Jun 23, 2020.

Ticagrelor Levels and Effects while Breastfeeding

Summary of Use during Lactation

No published information is available on the use of ticagrelor during breastfeeding. Because ticagrelor and its active metabolite are more than 99% bound to plasma proteins, the amount in milk is likely to be low. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. If it is used by a nursing mother, monitor the infant for bruising and bleeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Aspirin

Substance Identification

Substance Name

Ticagrelor

CAS Registry Number

274693-27-5

Drug Class

  • Breastfeeding
  • Lactation
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.